Charles Chan Selected Research

Charles Chan Research Topics

Disease

12	Neoplasms (Cancer) 01/2016 - 02/2010
10	Colorectal Neoplasms (Colorectal Cancer) 12/2015 - 04/2005
7	Ovarian Neoplasms (Ovarian Cancer) 01/2016 - 11/2011
6	Colonic Neoplasms (Colon Cancer) 05/2012 - 04/2005
4	Myocardial Infarction 10/2006 - 04/2002
4	Thrombosis (Thrombus) 10/2006 - 08/2003
3	Rectal Neoplasms (Rectal Cancer) 01/2017 - 01/2014
3	Cardiovascular Diseases (Cardiovascular Disease) 11/2008 - 05/2004
3	Hyperplasia 05/2004 - 01/2004
2	Ovarian Epithelial Carcinoma 11/2012 - 11/2011
2	Adenocarcinoma 12/2011 - 02/2010
2	Pathologic Constriction (Stenosis) 08/2004 - 08/2002
1	Hodgkin Disease (Hodgkin's Disease) 08/2021
1	Bowen's Disease (Disease, Bowen) 08/2021
1	Cicatrix (Scar) 08/2021
1	Myalgia 02/2021
1	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 02/2021
1	Breast Neoplasms (Breast Cancer) 01/2021
1	COVID-19 10/2020
1	Shock 10/2020
1	Multiple Sclerosis 01/2020
1	Chronic Urticaria 01/2020
1	Drug Hypersensitivity Syndrome 03/2018
1	Triple Negative Breast Neoplasms 07/2016
1	Melanoma (Melanoma, Malignant) 07/2016
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 07/2016
1	Neoplasm Metastasis (Metastasis) 01/2016
1	Papillary Thyroid Cancer 01/2014
1	Thyroid Neoplasms (Thyroid Cancer) 01/2014
1	Prediabetic State (Prediabetes) 01/2013
1	Hemorrhage 09/2012

Drug/Important Bio-Agent (IBA)

7	Proteins (Proteins, Gene)FDA Link 01/2016 - 04/2005
6	PlatinumIBA 01/2016 - 11/2011
5	Cisplatin (Platino)FDA LinkGeneric 10/2014 - 11/2011
4	PhytochemicalsIBA 10/2014 - 11/2011
4	Oxaliplatin (Eloxatin)FDA LinkGeneric 11/2013 - 11/2011
3	CurcuminIBA 10/2014 - 11/2012
3	Pharmaceutical PreparationsIBA 10/2014 - 11/2011
2	LigandsIBA 01/2021 - 10/2012
2	Biomarkers (Surrogate Marker)IBA 07/2016 - 12/2015
2	QuercetinIBA 10/2014 - 11/2011
2	epigallocatechin gallate (epigallocatechin-3-gallate)IBA 01/2014 - 11/2012
2	thymoquinoneIBA 01/2014 - 11/2011
2	ResveratrolIBA 01/2014 - 01/2012
2	Glutathione S-Transferase piIBA 05/2012 - 12/2011
2	Indicators and Reagents (Reagents)IBA 05/2010 - 04/2005
2	omega-Chloroacetophenone (Mace)IBA 11/2008 - 05/2004
2	MetalsIBA 11/2008 - 01/2004
2	Tissue Plasminogen Activator (Alteplase)FDA Link 08/2004 - 04/2002
2	Abciximab (ReoPro)FDA Link 08/2004 - 04/2002
2	PolymersIBA 05/2004 - 01/2004
1	pembrolizumabIBA 08/2021
1	RetinoidsIBA 08/2021
1	DystrophinIBA 02/2021
1	RNA (Ribonucleic Acid)IBA 02/2021
1	atezolizumabIBA 01/2021
1	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2020
1	Hydrocortisone (Cortisol)FDA LinkGeneric 10/2020
1	Alemtuzumab (Campath)FDA Link 01/2020
1	Antihypertensive Agents (Antihypertensives)IBA 03/2018
1	Perindopril FDA LinkGeneric 03/2018
1	Amlodipine (Norvasc)FDA LinkGeneric 03/2018
1	B7-H1 AntigenIBA 07/2016
1	Messenger RNA (mRNA)IBA 01/2016
1	Glutathione (Reduced Glutathione)IBA 01/2016
1	Molecular Chaperones (Chaperone, Molecular)IBA 01/2016
1	Cyclin B1IBA 03/2015
1	CyclinsIBA 03/2015
1	Cyclin D1IBA 03/2015
1	EpitopesIBA 01/2015
1	Urokinase Plasminogen Activator ReceptorsIBA 01/2015
1	Monoclonal AntibodiesIBA 01/2015
1	ChloridesIBA 10/2014
1	Capsaicin (Zostrix)FDA Link 10/2014
1	benzimidazoleIBA 10/2014
1	IodineIBA 01/2014
1	IntegrinsIBA 01/2014
1	Ursolic AcidIBA 01/2014
1	Betulinic AcidIBA 01/2014
1	GenisteinIBA 01/2014
1	XELOXIBA 12/2013
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 12/2013
1	AmphiregulinIBA 12/2013
1	Transforming Growth Factor alpha (TGF-alpha)IBA 12/2013
1	Platinum Compounds (Compounds, Platinum)IBA 11/2013
1	Carboplatin (JM8)FDA LinkGeneric 11/2013
1	Metformin (Glucophage)FDA LinkGeneric 01/2013
1	anethole (trans-anethole)IBA 11/2012
1	AntioxidantsIBA 11/2012
1	imidazoleIBA 10/2012
1	2-picolineIBA 10/2012
1	PalladiumIBA 10/2012
1	Inosine Triphosphate (ITP)IBA 09/2012

Therapy/Procedure

8	Stents 11/2008 - 08/2002
3	Adjuvant Chemotherapy 01/2017 - 02/2010
3	Therapeutics 01/2014 - 04/2005
3	Drug Therapy (Chemotherapy) 12/2013 - 11/2011
3	Percutaneous Coronary Intervention 11/2008 - 08/2003
1	Ligation 02/2021
1	Neoadjuvant Therapy 01/2017